Anastrozole
Apo-Nastrol contains the active substance anastrozole. Anastrozole belongs to a group of medicines called aromatase inhibitors. Apo-Nastrol is used to treat breast cancer in postmenopausal women.
Apo-Nastrol reduces the amount of the female sex hormone, estrogen, produced by the body. This is achieved by blocking the action of a substance (enzyme) called aromatase.
If any of the above situations apply to the patient, they should not take Apo-Nastrol. In case of doubts, consult a doctor or pharmacist.
Before starting to take Apo-Nastrol, the patient should discuss it with their doctor or pharmacist:
In case of doubts, consult a doctor or pharmacist.
In case of hospitalization, the patient should inform the medical staff that they are taking Apo-Nastrol.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take. This includes medicines that are available without a prescription and herbal medicines. Apo-Nastrol may affect the way some medicines work, and some medicines may affect Apo-Nastrol.
The patient should not take Apo-Nastrol if they are already taking one of the following medicines:
If the above situation applies to the patient, they should contact their doctor or pharmacist.
The patient should tell their doctor if:
Apo-Nastrol should not be taken during pregnancy and breastfeeding. The patient should stop taking Apo-Nastrol and consult their doctor if they become pregnant.
Before taking any medicine, the patient should consult their doctor or pharmacist.
It is unlikely that Apo-Nastrol will affect the patient's ability to drive or use machines. However, in patients taking Apo-Nastrol, cases of weakness and drowsiness have been observed. If this situation applies to the patient, they should contact their doctor or pharmacist.
If the patient has been diagnosed with an intolerance to some sugars, they should contact their doctor before taking the medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet, which means it is essentially "sodium-free".
This medicine should always be taken exactly as prescribed by the doctor or pharmacist. In case of doubts, consult a doctor or pharmacist.
Apo-Nastrol should be taken for as long as the doctor or pharmacist recommends. The treatment is long-term and may last for several years. In case of doubts, consult a doctor or pharmacist.
Apo-Nastrol should not be used in children and adolescents.
In case of an overdose, the patient should immediately consult their doctor.
In case of a missed dose, the patient should take the next dose the following day at the usual time.
The patient should not take a double dose (two doses at the same time) to make up for the missed dose.
The patient should not stop taking Apo-Nastrol without consulting their doctor.
In case of any further doubts about taking this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Apo-Nastrol can cause side effects, although not everybody gets them.
Apo-Nastrol reduces estrogen levels in the blood and may cause a decrease in bone mineral density. Therefore, some patients may be at increased risk of bone fractures. The treating doctor will assess the existing risk in accordance with the guidelines for bone health in postmenopausal women. The patient should discuss the existing risk and possible treatment with their doctor.
If any of the side effects worsen or if the patient experiences any side effects not listed in the leaflet, they should inform their doctor or pharmacist.
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181 C, 02-222 Warsaw, tel.: +48 22 49-21-301, fax: +48 22 49-21-309, website: https://smz.ezdrowie.gov.pl .
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton after EXP. The expiry date refers to the last day of the month.
Store in a temperature below 25°C.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Round, white, coated tablets. The medicine is available in blisters containing 28 or 30 coated tablets. Not all pack sizes may be marketed.
Marketing authorization holder:
Aurovitas Pharma Polska Sp. z o.o.
ul. Sokratesa 13D lok. 27
01-909 Warsaw
Poland
Manufacturer:
Doppel Farmaceutici S.R.L.
Via Martíri Delle Foibe 1
29016 Cortemaggiore (PC)
Italy
Genepharm S.A.
18 Marathonos Ave
15351 Pallini (Attiki)
Greece
To obtain more detailed information on the medicine and its names in the Member States of the European Economic Area, the patient should contact the marketing authorization holder.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.